BDBM261619 (S)-4-(1-benzyl-3-methyl-1H-pyrazol-5-yl)-1-(2,2-diphenylacetyl)piperazine-2-carboxylic acid::US9708275, Compound 16

SMILES Cc1cc(N2CCN([C@@H](C2)C(O)=O)C(=O)C(c2ccccc2)c2ccccc2)n(Cc2ccccc2)n1

InChI Key InChIKey=BUHVHDJJGQYGGD-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 261619   

TargetType-2 angiotensin II receptor(Human)
Novartis

US Patent
LigandPNGBDBM261619(US9708275, Compound 16 | (S)-4-(1-benzyl-3-methyl-...)
Affinity DataIC50: 40.3nMAssay Description:120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs.The binding r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent